Evaluation of an automated prothrombin assay using a chromogenic substrate

Area of Science:

• Clinical Chemistry
• Hematology
• Biochemical Assays

Background:

• Prothrombin determination is crucial for monitoring anticoagulant therapy.
• Traditional methods for prothrombin measurement can be time-consuming and subject to variability.
• Automated analytical platforms offer potential for improved efficiency and standardization.

Purpose of the Study:

• To evaluate the performance of a commercial chromogenic substrate assay for prothrombin determination.
• To assess the suitability of this assay for use on an automated clinical analyzer.
• To compare the results of the automated chromogenic assay with established methods like prothrombin time and Thrombotest.

Main Methods:

• Evaluation of a commercially available chromogenic substrate assay for prothrombin.
• Testing on an automated clinical analysis system.
• Analysis of 170 plasma samples from patients undergoing long-term oral anticoagulant therapy.
• Comparative analysis with prothrombin time and Thrombotest results.

Main Results:

• The chromogenic assay demonstrated satisfactory accuracy, precision, and sensitivity.
• The automated method was found to be rapid, simple, and exhibited negligible carry-over.
• Highly significant correlations were observed between the automated amidolytic prothrombin levels and those obtained by prothrombin time and Thrombotest methods.

Conclusions:

• The evaluated chromogenic substrate assay is a reliable and efficient method for automated prothrombin determination.
• This automated assay is suitable for clinical use, particularly for monitoring patients on oral anticoagulant therapy.
• The assay provides results that are highly comparable to conventional methods, enhancing diagnostic capabilities.